Search Filters

Search Results

Found 1 results

510(k) Data Aggregation

    K Number
    K955444
    Date Cleared
    1996-04-02

    (126 days)

    Product Code
    Regulation Number
    862.3320
    Reference & Predicate Devices
    N/A
    Why did this record match?
    Device Name :

    ABBOTT AXSM PROCAINAMIDE ASSAY

    AI/MLSaMDIVD (In Vitro Diagnostic)TherapeuticDiagnosticis PCCP AuthorizedThirdpartyExpeditedreview
    Intended Use

    for the quantitative determination of procainamide in human serum or plasma (sodium heparin, tripotassium EDTA, potassium oxalate, and sodium citrate).

    Device Description

    automated fluorescence polarization immunoassays (FPIA).

    AI/ML Overview

    This 510(k) summary (K955444) for the Abbott AxSYM Procainamide assay describes a comparison study against a predicate device, the TDx/TDxFLx Procainamide assay, to demonstrate substantial equivalence. It does not contain information typically found in studies for AI-powered diagnostic devices with "acceptance criteria" in the sense of accuracy, sensitivity, or specificity. Instead, the "acceptance criteria" here are implicitly related to the statistical similarity between the new device and the predicate.

    Here's an analysis based on the provided text:

    1. Table of Acceptance Criteria and Reported Device Performance

    MetricAcceptance Criteria (Implicit)Reported Device Performance
    SlopeClose to 1.00.98
    Y-InterceptClose to 0.00.1
    Correlation CoefficientClose to 1.0 (e.g., >0.95 or >0.98)0.989
    Standard Error of the Y estimateLow (specific threshold not stated, but 0.056 is reported)0.056

    Note: The "acceptance criteria" are implied by the goal of demonstrating substantial equivalence to the predicate device. For a correlation study, slopes close to 1, intercepts close to 0, and high correlation coefficients are generally desired to show agreement between two methods.

    2. Sample Size Used for the Test Set and Data Provenance

    • Sample Size: 205
    • Data Provenance: The document does not specify the country of origin or whether the data was retrospective or prospective. It only mentions "human serum or plasma."

    3. Number of Experts Used to Establish the Ground Truth for the Test Set and Qualifications of Those Experts

    This type of information is not applicable to this 510(k) summary. The "ground truth" for this device is the measurement provided by the predicate TDx/TDxFLx Procainamide assay. There were no human experts evaluating images or making diagnoses that required ground truth establishment.

    4. Adjudication Method for the Test Set

    Not applicable. This was a direct comparison of analytical measurements between two automated systems, not a diagnostic task requiring human adjudication.

    5. If a Multi-Reader Multi-Case (MRMC) Comparative Effectiveness Study Was Done

    No, an MRMC study was not done. This is a comparison of two automated laboratory assays, not a diagnostic imaging device where human readers would interpret results.

    6. If a Standalone (i.e. algorithm only without human-in-the-loop performance) Was Done

    Yes, in a sense. The study compares the performance of the AxSYM Procainamide assay (the algorithm/device) directly against the TDx/TDxFLx Procainamide assay (another algorithm/device) without human intervention in the measurement process. It's a standalone comparison of the two automated systems.

    7. The Type of Ground Truth Used

    The "ground truth" in this context is the measurement obtained from the predicate device, the TDx/TDxFLx Procainamide assay. This is a common approach for demonstrating substantial equivalence for in vitro diagnostic devices when a recognized predicate exists.

    8. The Sample Size for the Training Set

    The document does not mention a "training set" in the context of machine learning or AI. This is a traditional immunoassay validation. The AxSYM Procainamide assay itself was developed and calibrated, but the document does not detail specific training sample sizes for an algorithm. It mentions:

    • "The AxSYM Procainamide standard calibrators and controls are to be used with the AxSYM Procainamide reagents."
    • "Calibrators and controls are prepared gravimetrically using purified material obtained from commercial sources."
    • "The calibrators and controls are verified using protocols involving multiple instrument testing."

    These suggest internal validation and calibration processes, not a "training set" for predictive modeling.

    9. How the Ground Truth for the Training Set Was Established

    Not applicable for this type of device and study. The calibrators and controls for the AxSYM system are described as "prepared gravimetrically using purified material obtained from commercial sources" and "verified using protocols involving multiple instrument testing." This refers to the analytical accuracy of the calibrators themselves, which is different from establishing ground truth for a diagnostic algorithm's training data.

    Ask a Question

    Ask a specific question about this device

    Page 1 of 1